acetaminophen and ncx1000

acetaminophen has been researched along with ncx1000 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wallace, JL1
Antonelli, E; Del Soldato, P; Distrutti, E; Farneti, S; Fiorucci, S; Mencarelli, A; Morelli, A1

Other Studies

2 other study(ies) available for acetaminophen and ncx1000

ArticleYear
Acetaminophen hepatotoxicity: NO to the rescue.
    British journal of pharmacology, 2004, Volume: 143, Issue:1

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Liver; Mice; Nitrates; Nitric Oxide; Nitric Oxide Donors; Ursodeoxycholic Acid

2004
Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice.
    British journal of pharmacology, 2004, Volume: 143, Issue:1

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Apoptosis; Caspases; Cell Separation; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media; Cytosol; Hepatocytes; Liver; Liver Failure; Membrane Potentials; Mice; Mitochondria, Liver; Nitrates; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Sulfhydryl Compounds; Ursodeoxycholic Acid

2004